Clinical trial
The Expression and Effect of Cyr61 in Urinary Tract Transitional Cell Carcinoma
NCT01189838 is registered in ClinicalTrials.gov with Far Eastern Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Expression and Effect of Cyr61 in Urinary Tract Transitional Cell Carcinoma
- Lead sponsor
- Far Eastern Memorial Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2010
- Completion date
- December 31, 2010
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.